Biotechnology company focusing on immune-driven medicine
Issues related to Medicare coverage of multi-cancer early detection screening tests, including the Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R. 2407 & S. 2085). Issues related to supporting research pertaining to Minimal Residual Disease (MRD) testing, related to the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024 (H.R. 4368), and the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024 (S. 2131). Issues related to lab analysis and review of diagnostics and lab developed tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2023 (H.R. 2369).
MMM - Medicare/Medicaid BUD - Budget/Appropriations HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
ARNOLD & PORTER KAYE SCHOLER LLP
601 Massachusetts Ave. NW, Washington, DC, 20001, US
KATIE BROWN PETER DUYSHART CASEY BROUHARD PARI MODY BOBBY MCMILLIN KRISTINE BLACKWOOD EUGENIA PIERSON KATIE BROWN PETER DUYSHART CASEY BROUHARD PARI MODY BOBBY MCMILLIN KRISTINE BLACKWOOD EUGENIA PIERSON KATIE BROWN PETER DUYSHART CASEY BROUHARD PARI MODY BOBBY MCMILLIN KRISTINE BLACKWOOD EUGENIA PIERSON